Yao et al. have noted that BJRD ameliorates T2DM in rats by affecting the gut microbiota, enhancing intestinal permeability, and inhibiting the TLR4/NF-κB mediated inflammatory response (Yao et al. 2022). The gene discussed is TLR4; the disease is type 2 diabetes mellitus.